5AM Venture Management, LLC Long-Term Concentrated

CIK: 0001799883 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: Apr 29, 2020

Total Value ($000): $322,967 (100.0% shares, 0.0% debt)

Holdings (8)

— Aprea Therapeutics, Inc. 30.7%

Value ($000) $99,158 Shares 2,852,654 Est. Cost $45.89 Unrealized —

— Homology Medicines, Inc. 26.6%

Value ($000) $86,028 Shares 5,535,919 Est. Cost $20.70 Unrealized —

ARVN Arvinas, Inc. 12.5%

Value ($000) $40,300 Shares 1,000,000 Est. Cost $29.28 Unrealized +59.8%

CRNX Crinetics Pharmaceuticals, Inc. 8.5%

Value ($000) $27,376 Shares 1,862,286 Est. Cost $19.04 Unrealized +7.7%

CABA Cabaletta Bio, Inc. 8.3%

Value ($000) $26,786 Shares 3,669,263 Est. Cost $11.85 Unrealized +15.7%

— scPharmaceuticals Inc. 7.5%

Value ($000) $24,075 Shares 3,253,440 Est. Cost $5.66 Unrealized —

IDYA IDEAYA Biosciences, Inc. 4.4%

Value ($000) $14,268 Shares 3,463,066 Est. Cost $7.13 Unrealized -0.7%

— Cidara Therapeutics, Inc. 1.5%

Value ($000) $4,976 Shares 2,006,511 Est. Cost $3.84 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Aprea Therapeutics, Inc.	2,852,654	$99,158	30.7%	$45.89	—	COM	03836J102
—	Homology Medicines, Inc.	5,535,919	$86,028	26.6%	$20.70	—	COM	438083107
ARVN	Arvinas, Inc.	1,000,000	$40,300	12.5%	$29.28	+59.8%	COM	04335A105
CRNX	Crinetics Pharmaceuticals, Inc.	1,862,286	$27,376	8.5%	$19.04	+7.7%	COM	22663K107
CABA	Cabaletta Bio, Inc.	3,669,263	$26,786	8.3%	$11.85	+15.7%	COM	12674W109
—	scPharmaceuticals Inc.	3,253,440	$24,075	7.5%	$5.66	—	COM	810648105
IDYA	IDEAYA Biosciences, Inc.	3,463,066	$14,268	4.4%	$7.13	-0.7%	COM	45166A102
—	Cidara Therapeutics, Inc.	2,006,511	$4,976	1.5%	$3.84	—	COM	171757107